| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 125, 2221-2223, Copyright © 1989 by Endocrine Society
ARTICLES |
TP Segerson, KS Lam, L Cacicedo, N Minamitani, JS Fink, RM Lechan and S Reichlin
Division of Endocrinology, New England Medical Ctr., Boston, MA.
Vasoactive intestinal peptide (VIP) is a secretagogue for pituitary prolactin, but the importance of this peptide in the normal control of prolactin secretion is unclear. Recent studies suggest VIP synthesis within the rat anterior pituitary. We have shown (Endocrinology 124:1077) that the content of rat pituitary VIP increases in hypothyroidism. To confirm in situ pituitary synthesis of VIP and determine whether thyroid hormone effects on pituitary VIP relate to changes in VIP mRNA, Northern and in situ hybridization analyses of VIP mRNA in rat pituitaries were performed. Northern hybridization demonstrated an RNA species from rat pituitary consistent with rat VIP mRNA. Hypothyroidism increased the content of pituitary VIP mRNA, and replacement with 1-thyroxine prevented this increase. In situ hybridization showed multiple, widely-distributed hybridizing cells in pituitaries from hypothyroid animals. A distinct population of VIP- producing pituitary cells exists which may serve to modulate prolactin secretion in a paracrine or autocrine fashion.
This article has been cited by other articles:
![]() |
M Fernandez, F Sanchez-Franco, N Palacios, I Sanchez, and L Cacicedo IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1 J. Mol. Endocrinol., June 1, 2005; 34(3): 699 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gomez and J. A. Balsa Autocrine/Paracrine Action of Pituitary Vasoactive Intestinal Peptide on Lactotroph Hyperplasia Induced by Estrogen Endocrinology, October 1, 2003; 144(10): 4403 - 4409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Shadiack, Y. Sun, and R. E. Zigmond Nerve Growth Factor Antiserum Induces Axotomy-Like Changes in Neuropeptide Expression in Intact Sympathetic and Sensory Neurons J. Neurosci., January 15, 2001; 21(2): 363 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsuno, H. Katakami, N. Sanno, Y. Ogino, R. Y. Osamura, S. Matsukura, N. Shimizu, and T. Nagashima Pituitary Somatotroph Adenoma Producing Growth Hormone (GH)-Releasing Hormone (GHRH) with an Elevated Plasma GHRH Concentration: A Model Case for Autocrine and Paracrine Regulation of GH Secretion by GHRH J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3241 - 3247. [Abstract] [Full Text] |
||||
![]() |
R. P. Mohney and R. E. Zigmond Vasoactive Intestinal Peptide Enhances Its Own Expression in Sympathetic Neurons after Injury J. Neurosci., July 15, 1998; 18(14): 5285 - 5293. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |